Pediatric Stem Cell Transplant: Procedure, Recovery and Results

A pediatric stem cell transplant, also called a bone marrow transplant, restores blood-forming cells after they are damaged by disease or intensive treatment. It can be life-saving for selected children with cancers, bone marrow failure, immune disorders and inherited blood conditions, but recovery requires close specialist follow-up.

Overview: what is a pediatric stem cell transplant?

A pediatric stem cell transplant is a treatment that replaces unhealthy, absent or treatment-damaged blood-forming stem cells with healthy stem cells. These cells travel to the bone marrow, where they can begin making red blood cells, white blood cells and platelets. The procedure is also commonly called a bone marrow transplant, although stem cells are often collected from blood rather than directly from bone marrow.

For a child, transplantation is not usually a single operation. It is a carefully planned treatment pathway involving testing, preparation, cell infusion, infection prevention and long-term monitoring. The infusion itself is similar to receiving a blood transfusion; the intensive part is often the treatment before and recovery after it.

Doctors may recommend transplantation for certain leukemias and lymphomas, severe aplastic anemia, inherited blood disorders such as thalassemia or sickle cell disease, immune deficiencies and some metabolic conditions. The child’s diagnosis, overall health, prior treatment, available donor options and family circumstances all guide the decision.

How it works and who may be a candidate

Stem cells are collected either from the child or from a donor. In an autologous transplant, the child receives their own previously collected cells, usually after high-dose treatment for a cancer. In an allogeneic transplant, cells come from another person, such as a matched sibling, an unrelated volunteer donor or, in selected situations, a partially matched family member or stored cord blood unit.

Allogeneic transplantation may provide an added immune effect against some cancers because donor immune cells can recognize remaining cancer cells. However, donor cells can also react against the child’s tissues, causing graft-versus-host disease (GVHD). This balance is one reason transplant decisions require specialist assessment.

Before proceeding, the transplant team evaluates the child’s organ function, infection status, blood tests, disease control and ability to tolerate conditioning treatment. Donor tissue typing, often called HLA matching, is also central to planning an allogeneic transplant. Families are supported by pediatric hematology-oncology, infectious disease, nutrition, psychology, nursing and social work professionals throughout this process.

For children with inherited marrow disorders or blood cancers, the specialist team may also discuss related conditions and treatments, including leukemia and thalassemia, when these are relevant to the child’s diagnosis.

Pediatric stem cell transplant: step by step

Preparation commonly begins with central venous catheter placement, if the child does not already have one. This soft tube gives the care team reliable access for medicines, transfusions, blood sampling and stem cell infusion. The child will also have baseline heart, lung, kidney and liver assessments, as well as dental and infection checks when appropriate.

Next comes conditioning. This may involve chemotherapy, radiation therapy in selected cases, immune-suppressing medicines or a combination of approaches. Conditioning aims to make room in the marrow, reduce the disease when necessary and decrease the chance that the body will reject donor cells. Its intensity is tailored to the condition and the child’s health.

On transplant day, the stem cells are infused through the central line. The cells then circulate and find their way to the bone marrow. This is generally painless, though some children may experience temporary effects such as nausea, fever, chills or changes in blood pressure, which the clinical team monitors closely.

During the following days and weeks, the team watches for engraftment: the point at which the new cells start producing blood cells. Blood counts, symptoms, infections, medication levels and signs of rejection or GVHD are assessed frequently. Bone marrow transplant care includes coordinated monitoring before, during and after infusion.

Recovery timeline: from low blood counts to day 100

Recovery is individual, but the first month is typically the period of greatest day-to-day medical monitoring. After conditioning, blood counts fall before the transplanted cells have fully engrafted. The child may need transfusions, intravenous fluids, antibiotics or antiviral medicines, nutrition support and treatment for mouth sores, diarrhea, nausea or fatigue.

Engraftment often occurs over the next several weeks, although timing differs with the stem cell source, transplant type and individual circumstances. A rising neutrophil count is an important early sign that the marrow is beginning to recover. Discharge from hospital depends on stable recovery, safe medication plans, reliable caregiver support and the ability to attend frequent follow-up visits.

The first 100 days are a major early recovery milestone, particularly after an allogeneic transplant. Infection risk remains elevated, and acute GVHD, medication side effects and delayed blood-count recovery can occur. Families should follow instructions about hand hygiene, food safety, medicines, school attendance, visitors and promptly reporting symptoms.

After day 100, many children gradually return to more familiar routines, but immune recovery may take months or longer. The transplant team continues surveillance for chronic GVHD, infections, disease relapse where applicable, growth and development concerns, endocrine effects, fertility-related issues and emotional wellbeing. Vaccinations are often restarted according to an individualized schedule once the team considers it safe.

What are the worst days after a stem cell transplant?

For many children, the most difficult period is the interval after conditioning and before engraftment, often roughly days 5 to 20 after transplant. Blood counts are very low during this time, so fatigue, fever, infection risk, mouth and throat inflammation, nausea, poor appetite and diarrhea may be more likely. Not every child experiences these problems to the same degree.

The exact timing and severity depend on the conditioning regimen, the type of transplant, the child’s diagnosis and whether complications develop. Families may also find the emotional strain of isolation, disrupted sleep and extended hospital stays challenging. Pain relief, anti-nausea treatment, nutrition support and psychological care are important parts of transplant care.

A fever during this period needs urgent assessment because children with very low white blood cell counts may become unwell quickly. The transplant unit should provide clear instructions for calling the team or seeking emergency care, including guidance for fever, breathing changes, bleeding, severe pain, repeated vomiting or unusual sleepiness.

Benefits, risks and expected results

The potential benefit of transplant is restoration of healthy blood and immune cell production. For some conditions, it offers the best possibility of cure or long-term disease control. For other children, it may be used after cancer returns or does not respond adequately to initial treatments. The transplant team explains the goal in the context of the individual child’s condition.

Risks include serious infection, bleeding from low platelet counts, organ toxicity, infertility, delayed growth or hormonal effects, graft failure and disease relapse. After donor transplantation, acute or chronic GVHD may affect the skin, digestive tract, liver, eyes, mouth or other organs. Preventive medicines and early treatment can reduce some risks, but close follow-up is essential.

What is the survival rate for children who receive a bone marrow transplant? There is no single survival rate that applies to all children. Outcomes differ widely according to the disease being treated, whether the disease is in remission, donor compatibility, age, transplant approach, infection history and complications. A transplant center can discuss current outcome information relevant to the child’s diagnosis and treatment plan, while also explaining that population outcomes cannot predict one child’s result.

Families should ask about the purpose of transplant, expected benefits, key short- and long-term risks, donor options, alternatives and the monitoring plan. These discussions help caregivers give informed consent and prepare for the practical demands of recovery.

Do stem cells help kids with autism?

Stem cell transplantation is not an established treatment for autism spectrum disorder. Major medical and regulatory organizations do not recommend unproven stem cell interventions for autism outside properly designed and ethically approved clinical research. Autism is a neurodevelopmental condition, not a condition treated with standard bone marrow or blood stem cell transplantation.

Families may encounter online claims about stem cell clinics or treatments. Such claims can be difficult to assess and may expose children to financial harm, infection, immune reactions or other complications without proven benefit. Parents and caregivers should discuss any proposed stem cell treatment with the child’s pediatrician or a qualified pediatric specialist before making decisions.

Evidence-based autism support may include individualized developmental, educational, behavioral, communication and occupational therapies, alongside care for co-occurring medical or mental health needs. The most appropriate plan reflects the child’s strengths, support needs and family goals.

When to seek medical care

A child being evaluated for or recovering from a stem cell transplant should remain in close contact with the transplant team. Caregivers should seek urgent medical advice for fever according to the team’s stated threshold, chills, difficulty breathing, new cough, uncontrolled vomiting or diarrhea, inability to drink, severe mouth pain, unusual bleeding, a spreading rash, confusion or marked changes in alertness.

It is also important to contact the team promptly for line redness, drainage or pain; reduced urine output; new yellowing of the skin or eyes; worsening abdominal pain; or a missed dose of an important transplant medicine. Families should not wait for a routine appointment if they are concerned that the child is becoming unwell.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and treatment planning for international pediatric patients who may need transplant care. Families can ask their medical team about pediatric oncology care and related supportive services appropriate to the child’s condition.

Frequently asked questions

How long does a pediatric stem cell transplant take?

The stem cell infusion itself often takes several hours, depending on the cell product and the child’s needs. However, the full process includes pre-transplant testing, conditioning treatment, hospital recovery and long-term outpatient follow-up, which may extend for months or longer.

Is a stem cell transplant painful for a child?

The infusion is usually not painful because it is given through a central venous line. Some parts of treatment, such as mouth sores, nausea, procedures or complications from conditioning, can cause discomfort, and the team provides individualized symptom relief.

When can a child go back to school after a stem cell transplant?

The timing varies according to immune recovery, medication use, infection risk, energy levels and school setting. The transplant team will advise when attendance is safe and may recommend a gradual return, temporary home learning or specific precautions.

What happens after 100 days after stem cell transplant?

After day 100, follow-up remains important because immune recovery is still incomplete for many children. The team monitors for chronic graft-versus-host disease, infections, medication effects, relapse when relevant, growth and development, and plans for revaccination when appropriate.

Can parents donate stem cells to their child?

In some situations, a parent may be a potential partially matched donor. Whether this is suitable depends on tissue typing, the child’s diagnosis, transplant strategy and available donor sources; the transplant team will explain the safest options.

What foods should a child avoid after a stem cell transplant?

Food-safety precautions are often recommended while immune defenses are low, but the details vary by center and stage of recovery. Families should follow their transplant dietitian’s guidance, which may include avoiding undercooked animal foods, unpasteurized products and foods prepared or stored unsafely.

References

• World Health Organization
• National Cancer Institute
• Centers for Disease Control and Prevention
• European Society for Blood and Marrow Transplantation
• American Society of Hematology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.